These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37729058)

  • 1. Generation of mouse models carrying B cell restricted single or multiplexed loss-of-function mutations through CRISPR-Cas9 gene editing.
    Ten Hacken E; Gruber M; Hernández-Sánchez M; Hoffmann GB; Baranowski K; Redd RA; Clement K; Livak K; Wu CJ
    STAR Protoc; 2023 Dec; 4(4):102165. PubMed ID: 37729058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for the saturation and multiplexing of genetic variants using CRISPR-Cas9.
    Sahu S; Sullivan T; Southon E; Caylor D; Geh J; Sharan SK
    STAR Protoc; 2023 Dec; 4(4):102702. PubMed ID: 37948185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized protocol for gene editing in adipocytes using CRISPR-Cas9 technology.
    Qiu Y; Ding Q
    STAR Protoc; 2021 Mar; 2(1):100307. PubMed ID: 33554142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heritable CRISPR-Cas9 editing of plant genomes using RNA virus vectors.
    Uranga M; Aragonés V; Daròs JA; Pasin F
    STAR Protoc; 2023 Mar; 4(1):102091. PubMed ID: 36853698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools.
    Celotti M; Derks LLM; van Es J; van Boxtel R; Clevers H; Geurts MH
    STAR Protoc; 2024 Sep; 5(3):103189. PubMed ID: 39003744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR deactivation in mammalian cells using photocleavable guide RNAs.
    Zou RS; Liu Y; Ha T
    STAR Protoc; 2021 Dec; 2(4):100909. PubMed ID: 34746867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical-genetic CRISPR-Cas9 screens in human cells using a pathway-specific library.
    Hundley FV; Toczyski DP
    STAR Protoc; 2021 Sep; 2(3):100685. PubMed ID: 34382013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized electroporation of CRISPR-Cas9/gRNA ribonucleoprotein complex for selection-free homologous recombination in human pluripotent stem cells.
    Xu H; Kita Y; Bang U; Gee P; Hotta A
    STAR Protoc; 2021 Dec; 2(4):100965. PubMed ID: 34825222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized CRISPR/Cas9-mediated single nucleotide mutation in adherent cancer cell lines.
    Gao P; Dong X; Wang Y; Wei GH
    STAR Protoc; 2021 Jun; 2(2):100419. PubMed ID: 33870225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A user-friendly and streamlined protocol for CRISPR/Cas9 genome editing in budding yeast.
    Novarina D; Koutsoumpa A; Milias-Argeitis A
    STAR Protoc; 2022 Jun; 3(2):101358. PubMed ID: 35712010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplexed CRISPR-Cas9 protocol for large transgene integration into the Schistosoma mansoni genome.
    Ittiprasert W; Moescheid MM; Mann VH; Brindley PJ
    STAR Protoc; 2024 Mar; 5(1):102886. PubMed ID: 38354082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for efficient CRISPR-Cas9-mediated fluorescent tag knockin in hard-to-transfect erythroid cell lines.
    Deleuze V; Soler E; Andrieu-Soler C
    STAR Protoc; 2024 Jun; 5(2):103016. PubMed ID: 38640065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for editing fibroblasts with in vitro transcribed Cas9 mRNA and profile off-target editing by optimized GUIDE-seq.
    Li Z; Reint G; Haapaniemi EM
    STAR Protoc; 2023 Dec; 4(4):102662. PubMed ID: 37889758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for arrayed gRNA screening by base editors in mammalian cell lines using lentiviral system.
    Ravi NS; George A; Mohankumar KM
    STAR Protoc; 2023 Dec; 4(4):102668. PubMed ID: 37922314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute gene inactivation in the adult mouse liver using the CRISPR-Cas9 technology.
    Wang X; Xu BL; Chen XW
    STAR Protoc; 2021 Sep; 2(3):100611. PubMed ID: 34189476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
    Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
    Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol for gene characterization in Aspergillus niger using 5S rRNA-CRISPR-Cas9-mediated Tet-on inducible promoter exchange.
    Zheng X; Cairns T; Zheng P; Meyer V; Sun J
    STAR Protoc; 2022 Dec; 3(4):101838. PubMed ID: 36595926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generating mutant
    Li HH; Li JC; Su MP; Liu KL; Chen CH
    STAR Protoc; 2021 Jun; 2(2):100432. PubMed ID: 33899015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas9-Mediated Genomic Deletions Protocol in Zebrafish.
    Amorim JP; Bordeira-Carriço R; Gali-Macedo A; Perrod C; Bessa J
    STAR Protoc; 2020 Dec; 1(3):100208. PubMed ID: 33377102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for in vivo CRISPR screening using selective CRISPR antigen removal lentiviral vectors.
    Lane-Reticker SK; Kessler EA; Muscato AJ; Kim SY; Doench JG; Yates KB; Manguso RT; Dubrot J
    STAR Protoc; 2023 Mar; 4(1):102082. PubMed ID: 36861834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.